Thursday, 04 February 2016
  1 Replies
  8.1K Visits
  Subscribe
I realize that the TEMPO study suggests tolvaptan be used in patients with intact renal function (that is who they enrolled) but have you been using it for later stage CKD as well?

Dr. JS
5 years ago
·
#851
During the TEMPO trial patients with CKD function 1,2 and 3 were enrolled and found to benefit from tolvaptan, that is less kidney enlargment and less deterioration of renal function(as compared to placebo). There were no stage 4 patients, therefore the benefit here is not demonstrated but is presently being tested in an ongoing study (REPRISE).
  • Page :
  • 1
There are no replies made for this post yet.
Be one of the first to reply to this post!
Submit Your Response
Upload files or images for this discussion by clicking on the upload button below.
Supported: gif,jpg,png,zip,rar,pdf,jpeg,doc,docx,xls,xlsx
· Insert · Remove
  Upload Files (Maximum 10MB)

Sharing your current location while posting a new question allow viewers to identify the location you are located.

ukidneyisup